John Wilding - Publications, H-index & Citations

John Wilding

Aintree University Hospital

95H指数

736论文数

5.6W被引数

收录论文 249

发表时间

Implementing SGLT2 Inhibitor Therapy in Line with the New NICE Guidelines for Type 2 Diabetes Management 根据NICE新指南实施SGLT2抑制剂疗法用于2型糖尿病管理

Diabetes Therapy

IF2.6

2026-07-13

OAAI

Philip Newland-Jones; Partha Kar; Beth Kelly; Rahul Mohan; Sarah Davies; Jane Diggle; Marc Evans; Kevin Fernando; Debbie Hicks; Naresh Kanumilli; Nicola Milne; Dipesh Patel; Samuel Seidu; Adie Viljoen; David C. Wheeler; John P. H. Wilding

Randomised Controlled Feasibility Trial of Face-To-Face Diabetes Self-Management Education Shows High Completion Rates Are Needed to Improve Patient-Reported Outcomes 面对面糖尿病自我管理教育的随机对照可行性试验表明，需要高完成率才能改善患者报告结局

diabetes, obesity and metabolism

IF0

2026-05-27

OAAI

Gemma A. Lewis; David M. Hughes; Greg J. Irving; John P. Wilding; Kevin J. Hardy

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis 达格列净对伴有肝纤维化风险的2型糖尿病患者心血管结局的影响

diabetes, obesity and metabolism

IF0

2026-04-27

OAAI

Jan Oscarsson; Monika Huhn; Yunyun Jiang; Ingrid Gause-Nilsson; Stephen D. Wiviott; Filipe A. Moura; John P. H. Wilding; Simona Cernea; Luc Van Gaal; Avivit Cahn; Deepak L. Bhatt; Peter A. Johansson; C. David Sjöström

Enhancing economic modelling in obesity: integrating novel type 2 diabetes progression & obstructive sleep apnea remission – a UK case study 增强肥胖症经济建模：整合新型2型糖尿病进展与阻塞性睡眠呼吸暂停缓解——一项英国案例研究

Journal of Medical Economics

IF3

2026-04-22

OAAI

Lieven Annemans; Erin Johansson; Erik Spaepen; Naomi van Hest; Josephine Grist; Sarah Zimner-Rapuch; John P. H. Wilding

Cost-effectiveness of tirzepatide versus semaglutide for patients with obesity or overweight in the US: evidence from the SURMOUNT-5 head-to-head phase-3 trial 曲美替肽与司美格鲁肽治疗美国超重或肥胖患者的成本效益比较：来自SURMOUNT-5头对头III期试验的证据

Journal of Medical Economics

IF3

2026-04-21

OAAI

Erin Johansson; John P. H. Wilding; Navneet Upadhyay; Naomi van Hest; Myles Kirk; Erik Spaepen; Sarah Zimner-Rapuch; Lieven Annemans; Harold Bays

Real-world completion of diabetes self management education and its impact on patient-reported outcomes: A scoping review 糖尿病自我管理教育的实际完成情况及其对患者报告结局的影响：一项范围综述

Diabetic Medicine

IF3.4

2026-04-03

OAAI

Gemma Lewis; David M. Hughes; Greg Irving; John Wilding; Kevin Hardy

Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023 2014年至2023年韩国成人临床与前期肥胖研究

Diabetes & Metabolism Journal

IF8.5

2026-01-01

OAAI

Choe, Hun Jee; Despres, Jean-Pierre; Wilding, John P. H.; Ryan, Donna H.; Lim, Soo

Diabetes self-management education and its association with hospital admissions and premature mortality: A scoping review and meta-analysis 糖尿病自我管理教育及其与住院 admission 和过早死亡率的关系：一项范围综述和荟萃分析

DIABETES OBESITY & METABOLISM

IF5.7

2025-11-01

PREAI

Lewis, Gemma A.; Hughes, David M.; Irving, Greg; Wilding, John; Hardy, Kevin

Tirzepatide and the NHS: are we creating atwo-tier obesity treatment system?Tirzebatide和NHS: 我们正在创建一个两级肥胖治疗系统吗？

BRITISH JOURNAL OF GENERAL PRACTICE

IF5.2

2025-11-01

OAAI

Dobbie, Laurence J.; Molokhia, Mariam; Wilding, John Ph; Tan, Tricia M-M; McGowan, Barbara

Galectin-3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE-TIMI 58 Galectin-3与使用达格列净治疗的2型糖尿病患者的肾功能：DECLARE-TIMI 58研究分析

ESC Heart Failure

IF3.7

2025-09-15

OAAI

Paul M. Haller; Stephen D. Wiviott; David D. Berg; Petr Jarolim; Erica L. Goodrich; Deepak L. Bhatt; Ingrid Gause-Nilsson; Lawrence A. Leiter; Darren K. McGuire; John P.H. Wilding; Itamar Raz; Marc S. Sabatine; David A. Morrow

Rising to the challenges of research in multiple long-term conditions: health and social care research ecosystem approaches 应对多种长期病症研究的挑战：健康和社会护理研究生态系统的途径

BMJ OPEN

IF2.3

2025-09-14

OAAI

De Soyza, Anthony; Goodwin, Victoria A.; Roberts, Kate; Masoli, Jane; Mathews, Jacqueline; Wilding, John; Nestor, Gary; Bower, Peter

Variation in the Commissioning of Semaglutide for the Treatment of Obesity and Overweight Across England: Results of Three Freedom of Information-Based Mapping Exercises Across the 42 Integrated Care Boards of England 英格兰地区肥胖症和超重治疗中司美格鲁肽使用授权的差异性：基于英格兰42个综合医疗委员会的三项信息公开映射研究的结果

CLINICAL OBESITY

IF2.1

2025-09-01

OAAI

de Bray, Anne; Schnitzer, Hanna; Mahase, Elisabeth; Singh, Puspha; Andrews, Rob; Mcgowan, Barbara M.; Le Brocq, Sarah; Wilding, John P. H.; Flint, Stuart W.; Hazlehurst, Jonathan M.

Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study)不同生活方式方法在多中心、开放标签、平行组、随机对照试验中整合实用化方案以开具利拉鲁肽3.0 mg用于体重管理服务的效果研究（STRIVE研究）的结局。

Metabolites 2025, Vol. 15, Page 398

IF3.7

2025-08-22

PREAI

Werd Al-Najim; Babak Dehestani; Ahmed W. Al-Humadi; Danielle H. Bodicoat; Dimitris Papamargaritis; Michael Lean; Barbara McGowan; David R. Webb; John PH Wilding; Melanie J. Davies; Carel W. le Roux

Defective lymphatic vasculature in obesity 肥胖中的淋巴管缺陷

Obesity Reviews

IF7.4

2025-03-27

OAAI

Jingjing Zhu; John P. H. Wilding; Ji Hu

Systematic development of a complex intervention: a theory and evidence-based physiotherapist led group intervention to increase physical activity and reduce sedentary behaviour following bariatric surgery (PARIS)

physiotherapy

IF3

2025-03-01

OAAI

James, Jennifer; Hardeman, Wendy; Goodall, Mark; Eborall, Helen; Wilding, John P. H.

Tirzepatide for Older Adults with Type 2 Diabetes and Without Obesity: A Post Hoc Analysis of the SURPASS Clinical Trials Tirzepatide治疗无肥胖的2型糖尿病老年患者：SURPASS临床研究的回顾性分析

DIABETES THERAPY

IF2.6

2025-02-28

OAAI

Rasouli, Neda; Wilding, John P. H.; Kwan, Anita Y. M.; Paik, Jim S.; Sharma, Palash; Peleshok, Jennifer

Association between diabetes self-management education attendance, hospital admissions and mortality in type 2 diabetes: A cohort analysis protocol

DIABETES OBESITY & METABOLISM

IF5.7

2025-02-19

OAAI

Lewis, Gemma A.; Hughes, David M.; Irving, Greg; Wilding, John; Hardy, Kevin

Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial

OBESITY

IF4.7

2025-02-13

OAAI

Kushner, Robert F.; Ryan, Donna H.; Deanfield, John; Kokkinos, Alexander; Cercato, Cintia; Wilding, John; Burguera, Bartolome; Wu, Chau-Chung; Craciun, Anca-Elena; Pall, Denes; Hramiak, Irene; Hjelmesaeth, Joran; Harder-Lauridsen, Nina M.; Weimers, Petra; Jeppesen, Ole Kleist; Kallenbach, Klaus; Lincoff, A. Michael; Lingvay, Ildiko

Galectin-3 and Progression of Kidney Disease in Patients With Type 2 Diabetes Mellitus: Analyses From the DECLARE-TIMI 58 Trial Galectin-3与2型糖尿病 mellitus患者肾脏疾病进展：来自DECLARE-TIMI 58试验的分析

CIRCULATION

IF38.6

2024-11-12

PREAI

Haller, Paul; Wiviott, Stephen; Berg, David; Jarolim, Petr; Goodrich, Erica; Bhatt, Deepak; Cahn, Avivit; Gause-Nilsson, Ingrid; Leiter, Lawrence; McGuire, Darren; Raz, Itamar; Wilding, John; Sabatine, Marc; Morrow, David

The cumulative impact of type 2 diabetes and obstructive sleep apnoea on cardiovascular, liver, diabetes-related and cancer outcomes

DIABETES OBESITY & METABOLISM

IF5.7

2024-11-11

OAAI

Riley, David R.; Henney, Alex; Anson, Matthew; Hernadez, Gema; Zhao, Sizheng S.; Alam, Uazman; Wilding, John P. H.; Craig, Sonya; Cuthbertson, Daniel J.

研究方向